Venn Life Sciences Holdings PLC Completion of Sale (5204P)
18 November 2016 - 6:01PM
UK Regulatory
TIDMVENN
RNS Number : 5204P
Venn Life Sciences Holdings PLC
18 November 2016
Venn Life Sciences Holdings Plc
("Venn" or the "Company")
Completion of Sale
Venn Life Sciences (AIM: VENN), a growing Contract Research
Organisation providing drug development, clinical trial management
and resourcing solutions to pharmaceutical, biotechnology and
medical device clients, announces that further to the announcements
on 4 October 2016 and 27 October 2016 it has completed the sale of
its shareholding in Innovenn UK Limited to Integumen Limited and
that Integumen Limited is currently going through an IPO process.
Venn is receiving ordinary shares of GBP1.00 each in Integumen as
consideration.
Enquiries:
Venn Life Sciences Holdings www.vennlifesciences.com
Plc
Tony Richardson, Chief Executive Tel: +353 154 99 341
Officer
Jonathan Hartshorn, Chief Financial Tel: +353 153 93 269
Officer
Aoife O Farrell, Marketing Tel: +353 153 93 269
Manager
Davy (Nominated Adviser, ESM Tel: +353 1 679 6363
Adviser and Joint Broker)
Fergal Meegan / Matthew DeVere
White (Corporate Finance)
Paul Burke (Corporate Broking)
Hybridan LLP (Joint-Broker)
Claire Louise Noyce Tel: 020 3764 2341
Walbrook PR Ltd Tel: 020 7933 8787 or
venn@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
About Venn Life Sciences: Venn Life Sciences is a Contract
Research Organisation providing drug development, clinical trial
management and resourcing solutions to pharmaceutical,
biotechnology and medical device organisations. With dedicated
operations in France, Germany, the Netherlands, the UK, Ireland and
Europe wide representation - Venn Life Sciences specialises in
rapid deployment and management of multisite projects, across all
phases.
For more information about the Company, please visit:
www.vennlifesciences.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
DISDDBDBUUBBGLR
(END) Dow Jones Newswires
November 18, 2016 02:00 ET (07:00 GMT)
Hvivo (LSE:HVO)
Historical Stock Chart
From Apr 2024 to May 2024
Hvivo (LSE:HVO)
Historical Stock Chart
From May 2023 to May 2024